M. Horellou

发表

Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation.

M. Samama, I. Gouin-Thibault, I. Elalamy, 2002, Thrombosis research.

Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency.

J. Griffin, A. Gruber, K. Bauer, 1993, Blood.

Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.

F. Chédru, M. Bousser, M. Samama, 1996, Stroke.

Successful Progressive Anticoagulation in a Severe Protein C Deficiency and Previous Skin Necrosis at the Initiation of Oral Anticoagulant Treatment

J. Soria, J. Conard, M. Samama, 1984, Thrombosis and Haemostasis.

Peripheral-T-cell lymphoma with hemophagocytic histiocytosis localised to the bone marrow associated with inappropriate secretion of antidiuretic hormone.

J. Rossert, A. Bernadou, R. Favier, 1995, Leukemia & lymphoma.

Thrombosis and Pregnancy in Congenital Deficiencies in AT III, Protein C or Protein S: Study of 78 Women

M. Samama, T. Lecompte, J. Conard, 1990, Thrombosis and Haemostasis.

Acquired hemophilia due to factor VIII inhibitors in 34 patients.

J. Pouchot, O. Chosidow, R. Zittoun, 1998, The American journal of medicine.

Risk of thrombosis in patients homozygous for factor V Leiden.

M. Trossaërt, I. Elalamy, J. Conard, 1995, Blood.

Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin

J. Conard, C. Lecrubier, M. Samama, 2005, Agents and Actions.

Cerebral infarction and familial protein S deficiency.

P. Davous, J. Conard, M. Samama, 1990, Stroke.

Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgery.

M. Samama, P. Girard, J. Conard, 1991, Thrombosis research. Supplement.

[Two new anticoagulants available in 2010--Dabigatran Etexilate and Rivaroxaban: expected progresses--raised problems].

F. Depasse, M. Samama, J. Conard, 2010, Annales pharmaceutiques francaises.

Congenital protein C deficiency and thrombotic disease in nine French families.

M. Samama, R. Bertina, J. Conard, 1984, British medical journal.

A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.

C. Mannhalter, M. Horellou, A. Zivelin, 1998, Blood.

Retinal arterial occlusion associated with resistance to activated protein C.

B. Wechsler, N. Cassoux, P. Godeau, 1996, The British journal of ophthalmology.

Central retinal vein thrombosis associated with resistance to activated protein C.

R. Dhôte, C. Bachmeyer, P. Toulon, 1995, American journal of ophthalmology.

Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.

E. Kruithof, J. Conard, M. Samama, 1988, Blood.

Persistent Heparin Induced Thrombocytopenia Despite Therapy with Low Molecular Weight Heparin

A. Bernadou, M. Samama, G. D. Di Maria, 1984, Thrombosis and Haemostasis.

PREGNANCY AND CONGENITAL DEFICIENCY IN ANTITHROMBIN III OR PROTEIN C

M. Samama, J. Conard, M. Horellou, 1987, Thrombosis and Haemostasis.

Spontaneous platelet aggregation in heparin-treated patients.

M. Samama, J. Conard, C. Lecrubier, 1984, Acta haematologica.

Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases

L. Mouthon, N. Stieltjes, V. Roussel‐Robert, 2006, Transfusion medicine.

Laboratory Diagnosis of Antiphospholipid Antibodies

J. Conard, M. Samama, M. Horellou, 1997, Infectious diseases in obstetrics and gynecology.

Frequency of the 20210 G-->A mutation in the 3'-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis.

V. Biousse, M. Bousser, J. Conard, 1998, Stroke.

Frequency of the 20210 G 3 A Mutation in the 3 (cid:42) -Untranslated Region of the Prothrombin Gene in 35 Cases of Cerebral Venous Thrombosis

V. Biousse, M. Bousser, A. Ameri, 1998 .

Modified APC resistance assay for patients on oral anticoagulants

M. Trossaërt, H. Ireland, J. Conard, 1994, The Lancet.

COMPARISON OF THROMBOLYTIC, FIBRINOLYTIC, AND FIBRINOGENOLYTIC PROPERTIES OF TISSUE PLASMINOGEN ACTIVATOR, STREPTOKINASE, SINGLE‐CHAIN UROKINASE, HIGH MOLECULAR WEIGHT AND LOW MOLECULAR WEIGHT UROKINASE IN HUMAN PLASMA IN VITRO

A. Vahanian, P. Desnoyers, J. Conard, 1988, Fundamental & clinical pharmacology.

Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: A report of four patients

M. Samama, J. Conard, J. Audouin, 1991, American journal of hematology.

Low-dose heparin in gynecologic surgery: effect on blood coagulation tests.

J. Conard, M. Samama, A. Kher, 1981, Haemostasis.

Heparin-induced thrombocytopenia: laboratory diagnosis and management.

I. Elalamy, J. Conard, C. Lecrubier, 2000, Annals of medicine.

Familial and constitutional bleeding disorder due to platelet cyclo‐oxygenase deficiency

B. Vargaftig, M. Chignard, F. Fouque, 1983, American journal of hematology.

α2-Antiplasmin Assay: Amidolytic and Immunological Method. Critical Evaluation. Results in a Clinical Material

J. Conard, N. Schlegel, M. Samama, 1980 .

Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies.

P. Mannucci, P. Mannucci, G. Finazzi, 1984, Blood.

Leu 697-->Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease.

T. Vink, C. Mazurier, C. Gaucher, 1994, Blood.

Skin necrosis due to fluindione treatment: a rare but serious complication.

N. Dupin, S. Jacobelli, M. Avril, 2014, Journal of wound care.

The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum

D. Grabli, M. Giroud, F. Sedel, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

ANTITHROMBIN III AND ORAL CONTRACEPTION WITH PROGESTAGEN-ONLY PREPARATION

J. Conard, M. Samama, J. Zorn, 1979, The Lancet.

Treatment of Hereditary Protein C Deficiency with Stanozolol

C. Kluft, R. Bertina, J. Conard, 1987, Thrombosis and Haemostasis.

[Association of dysfibrinogenemia and thrombosis. Apropos of a family (Fibrinogen Melun) and review of the literature].

P. Ffrench, J. Conard, M. Samama, 1995, Annales de medecine interne.

Heterogeneous mechanisms responsible for reduced fibrinolytic capacity in patients with a history of venous thrombosis

M. Samama, J. Conard, S. Combe, 1994 .

Bovine or human thrombin in amidolytic at III assays. Influence of heparin cofactor II.

M. Samama, J. Conard, L. Bara, 1986, Thrombosis research.

Incidence of thromboembolism in association with congenital disorders in coagulation and fibrinolysis.

M. Samama, J. Conard, M. Horellou, 1988, Acta chirurgica Scandinavica. Supplementum.

Leiden factor V mutation in four patients with small bowel infarctions.

D. Heresbach, R. Fauchet, B. Messing, 1997, Gastroenterology.

DECREASE IN PROTEIN C IN L‐ASPARAGINASE‐TREATED PATIENTS

R. Zittoun, J. Conard, F. Potevin, 1985, British journal of haematology.

A vitamin K epoxide reductase complex subunit‐1 (VKORC1) mutation in a patient with vitamin K antagonist resistance

M. Loriot, L. Bodin, C. Flaujac, 2005, Journal of thrombosis and haemostasis : JTH.

[Anticardiolipin antibodies and thrombosis].

J. Conard, M. Samama, M. Horellou, 1995, Presse medicale.

[Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports].

D. Fassin, M. Samama, B. Wechsler, 1988, Journal des maladies vasculaires.

Acquired von willebrand disease: Correction of hemostatic defect by high‐dose intravenous immunoglobulins

C. Girard-Longhini, A. Delmer, R. Zittoun, 1992, American journal of hematology.

Diagnosis and clinical characteristics of inherited activated protein C resistance.

M. Trossaërt, I. Elalamy, J. Conard, 1996, Haemostasis.

Atypical mutations of the prothrombin gene at positions 20 209 and 20 218, and a novel mutation at position 20 219. Report on 10 patients

J. Conard, L. Le Flem, C. Flaujac, 2007, Journal of thrombosis and haemostasis : JTH.

Laboratory monitoring of a low molecular weight heparin (enoxaparin) with a new clotting test (Heptest).

J. Conard, L. Bara, M. Samama, 1987, Haemostasis.

Homozygous protein C deficiency with late onset and recurrent coumarin-induced skin necrosis

P. Reitsma, M. Samama, R. Bertina, 1992, The Lancet.

Fibrinogen Paris IX: a case of symptomatic hypofibrinogenemia with Bβ Y236C and Bβ IVS7‐1G→C mutations

P. de Mazancourt, J. Conard, V. Mathieux, 2006, Journal of thrombosis and haemostasis : JTH.

Proposed classification of resistances to oral anticoagulant therapy.

J. Lefrère, J. Conard, M. Samama, 1987, Journal of clinical pathology.

Influence of Storage Conditions on Activated Protein C Resistance Assay

M. Trossaërt, J. Conard, M. Samama, 1995, Thrombosis and Haemostasis.

French Multicentric Evaluation of Recombinant Tissue Factor (Recombiplastin) for Determination of Prothrombin Time

J. Schved, L. Drouet, J. Sampol, 1994, Thrombosis and Haemostasis.

Low Levels of Protein S Activity in Factor V Depleted Plasma Used in APC Resistance Test

J. Amiral, I. Gouin-Thibault, J. Conard, 1998, Thrombosis and Haemostasis.

Vitamin K metabolism in a patient resistant to vitamin K antagonists.

M. Trossaërt, M. Samama, F. Parent, 1997, Haemostasis.

[Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations].

M. Trossaërt, I. Elalamy, J. Conard, 1995, Presse medicale.

The fibrinolytic system in patients with congenital protein C deficiency.

M. Samama, R. Bertina, J. Conard, 1984, Thrombosis research.

Is there a role for antiangiogenic therapy, bevacizumab, in the treatment of recurrent digestive bleeding due to angiodysplasia in Glanzmann's thrombasthenia?

R. Coriat, N. Stieltjes, V. Roussel‐Robert, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.